The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma

SUMMARY Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance produced and the primary tumor. Hypercalcemia is a frequent complication in cancer patients. Prognosis of cancer patients with hypercalcemia is usually poor. A factor called parathyroid hormone related peptide, whose actions are similar to those of the parathyroid hormone, is thought to be the most common cause of malignancy associated hypercalcemia. Non-islet hypoglycemic cell tumor consists of a rare syndrome characterized by the presence of a solid tumor and severe fasting hypoglycemia determined by an insulin-independent pathway. We report a case of a 59-year-old-man with a renal tumor and a T-cell rich large B cell lymphoma who was hospitalized due to severe hypercalcemia and hypoglycemia. The laboratory examination reported hypercalcemia with inhibited PTH and hypoglycemia with inhibited insulin secretion, arriving to the conclusion of tumoral peptide production. He received denosumab and corticoid therapy. The patient died one month later despite initial improvement after medical treatment. While a single paraneoplastic manifestation may be expected in most tumors, the coexistence of two or more of them is rare, except in hepatocellular carcinomas, and it has not yet been described in renal tumors.

Saved in:
Bibliographic Details
Main Authors: Soutelo,Jimena, Moldes,Sofía, Frisone,Cielo, Salvá,Laura, Agostinis,Cecilia, Faraj,Gabriel
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000100098
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972017000100098
record_format ojs
spelling oai:scielo:S2359-399720170001000982017-02-20The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphomaSoutelo,JimenaMoldes,SofíaFrisone,CieloSalvá,LauraAgostinis,CeciliaFaraj,GabrielSUMMARY Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance produced and the primary tumor. Hypercalcemia is a frequent complication in cancer patients. Prognosis of cancer patients with hypercalcemia is usually poor. A factor called parathyroid hormone related peptide, whose actions are similar to those of the parathyroid hormone, is thought to be the most common cause of malignancy associated hypercalcemia. Non-islet hypoglycemic cell tumor consists of a rare syndrome characterized by the presence of a solid tumor and severe fasting hypoglycemia determined by an insulin-independent pathway. We report a case of a 59-year-old-man with a renal tumor and a T-cell rich large B cell lymphoma who was hospitalized due to severe hypercalcemia and hypoglycemia. The laboratory examination reported hypercalcemia with inhibited PTH and hypoglycemia with inhibited insulin secretion, arriving to the conclusion of tumoral peptide production. He received denosumab and corticoid therapy. The patient died one month later despite initial improvement after medical treatment. While a single paraneoplastic manifestation may be expected in most tumors, the coexistence of two or more of them is rare, except in hepatocellular carcinomas, and it has not yet been described in renal tumors.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.61 n.1 20172017-02-01info:eu-repo/semantics/reporttext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000100098en10.1590/2359-3997000000212
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Soutelo,Jimena
Moldes,Sofía
Frisone,Cielo
Salvá,Laura
Agostinis,Cecilia
Faraj,Gabriel
spellingShingle Soutelo,Jimena
Moldes,Sofía
Frisone,Cielo
Salvá,Laura
Agostinis,Cecilia
Faraj,Gabriel
The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
author_facet Soutelo,Jimena
Moldes,Sofía
Frisone,Cielo
Salvá,Laura
Agostinis,Cecilia
Faraj,Gabriel
author_sort Soutelo,Jimena
title The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
title_short The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
title_full The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
title_fullStr The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
title_full_unstemmed The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
title_sort coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and b cell lymphoma
description SUMMARY Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance produced and the primary tumor. Hypercalcemia is a frequent complication in cancer patients. Prognosis of cancer patients with hypercalcemia is usually poor. A factor called parathyroid hormone related peptide, whose actions are similar to those of the parathyroid hormone, is thought to be the most common cause of malignancy associated hypercalcemia. Non-islet hypoglycemic cell tumor consists of a rare syndrome characterized by the presence of a solid tumor and severe fasting hypoglycemia determined by an insulin-independent pathway. We report a case of a 59-year-old-man with a renal tumor and a T-cell rich large B cell lymphoma who was hospitalized due to severe hypercalcemia and hypoglycemia. The laboratory examination reported hypercalcemia with inhibited PTH and hypoglycemia with inhibited insulin secretion, arriving to the conclusion of tumoral peptide production. He received denosumab and corticoid therapy. The patient died one month later despite initial improvement after medical treatment. While a single paraneoplastic manifestation may be expected in most tumors, the coexistence of two or more of them is rare, except in hepatocellular carcinomas, and it has not yet been described in renal tumors.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000100098
work_keys_str_mv AT soutelojimena thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT moldessofia thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT frisonecielo thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT salvalaura thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT agostiniscecilia thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT farajgabriel thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT soutelojimena coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT moldessofia coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT frisonecielo coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT salvalaura coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT agostiniscecilia coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
AT farajgabriel coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma
_version_ 1756441365766471680